Status:
WITHDRAWN
Pharmacological Study of Cefazolin Antibioprophylaxis in Liver Transplantation
Lead Sponsor:
University Hospital, Tours
Conditions:
Liver Transplant Infection
Surgical Site Infection
Eligibility:
All Genders
18+ years
Brief Summary
This study describes Cefazolin pharmacokinetics variation to target levels during liver transplantation.
Detailed Description
Cefazolin is one of the many drugs used in antibiotic prophylaxis during liver transplantation. However there are no study describing its pharmacokinetics during liver transplantation. Due to the sev...
Eligibility Criteria
Inclusion
- Age over 18
- patient undergoing liver transplantation
- receiving Cefazolin as perioperative antibiotic prophylaxis to prevent surgical site infections
Exclusion
- pregnant women
- legal protection or protected adults
- ongoing antibiotic treatment before liver transplantation
- patient inability to receive information or express opposition to the study.
- patient refusing participation
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 18 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04280237
Start Date
March 1 2020
End Date
March 18 2020
Last Update
April 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Surgical intensive care unit, University Hospital, Tours
Tours, France, 37044